Back to search

Article

Cost-Utility of Dalbavancin as a Treatment Option for Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Canada

2024-11-07

Abstract excerpt

<h4>Background: </h4> /Objectives: The standard of care for acute bacterial skin and skin structure infections (ABSSSIs) requiring intravenous (IV) antibiotics includes vancomycin, administered over several days, in a hospital or outpatient setting resulting in significant costs. Dalbavancin, a long-acting single-dose lipoglycopeptide IV therapy may offer a cost-effective option for adult patients with ABSSSIs in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
791d594a-125e-5b1c-bfa3-4d324c9f938f
DOI
10.20944/preprints202411.0514.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cost-Utility of Dalbavancin as a Treatment Option for Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in CanadaDOI 10.20944/preprints202411.0514.v1
Select a neighboring publication to make it the new centre.